Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marium Husain

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
Frontiers in Oncology|April 10, 2023
The state of cancer research in fragile and conflict-affected settings in the Middle East and North Africa Region: A bibliometric analysisZahi Abdul Sater, Theresa Farhat, Mohamed N Elsayed, et al.
BMC Cancer|April 7, 2023
Clinical markers of immunotherapy outcomes in advanced sarcomaMarium Husain, Dionisia Quiroga, Han Gil Kim, et al.
Cancers|February 27, 2026
Clear Cell and Histiocytic/Dendritic Cell Sarcomas: Clinical Outcomes, Molecular Features, and Diagnostic PitfallsGabriel Tinoco, Marium Husain, David Liebner, et al.
Nutrition and Cancer|May 4, 2026
How the Ketogenic Diet Shapes the Microbiome to Influence Cancer Immunotherapy Outcomes: An Exploration of Clinical Trials and Their ResultsJonah Bukovac, Marium Husain, Teryn Sapper, et al.
Journal of Cancer Research and Clinical Oncology|August 2, 2019
Change in neutrophil to lymphocyte ratio during immunotherapy treatment is a non-linear predictor of patient outcomes in advanced cancersMingjia Li, Daniel Spakowicz, Jarred Burkart, et al.
Cancer Immunology, Immunotherapy : CII|February 4, 2023
Association of medical comorbidities and cardiovascular disease with toxicity and survival among patients receiving checkpoint inhibitor immunotherapyAndrew C Johns, Mike Yang, Lai Wei, et al.
The Oncologist|April 21, 2023
Risk Factors for Immune Checkpoint Inhibitor Immunotherapy Toxicity Among Older Adults with CancerAndrew C Johns, Mike Yang, Lai Wei, et al.
Cancer Immunology, Immunotherapy : CII|July 31, 2020
Brief report: inhaled corticosteroid use and the risk of checkpoint inhibitor pneumonitis in patients with advanced cancerMingjia Li, Daniel Spakowicz, Songzhu Zhao, et al.
Asia-Pacific Journal of Clinical Oncology|December 20, 2024
Impact of Tobacco, Marijuana, and Alcohol Use on Overall Survival in Recurrent Metastatic Head and Neck Cancer Patients Treated With Immune Checkpoint InhibitorsMohammad Bilal Alsavaf, Majd Issa, Brett G Klamer, et al.
Journal of Cancer Research and Clinical Oncology|September 7, 2022
Immune checkpoint inhibitor-induced hepatitis injury: risk factors, outcomes, and impact on survivalAbdul Miah, Gabriel Tinoco, Songzhu Zhao, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Frontiers in Oncology|April 10, 2023
The state of cancer research in fragile and conflict-affected settings in the Middle East and North Africa Region: A bibliometric analysisZahi Abdul Sater, Theresa Farhat, Mohamed N Elsayed, et al.
BMC Cancer|April 7, 2023
Clinical markers of immunotherapy outcomes in advanced sarcomaMarium Husain, Dionisia Quiroga, Han Gil Kim, et al.
Cancers|February 27, 2026
Clear Cell and Histiocytic/Dendritic Cell Sarcomas: Clinical Outcomes, Molecular Features, and Diagnostic PitfallsGabriel Tinoco, Marium Husain, David Liebner, et al.
Nutrition and Cancer|May 4, 2026
How the Ketogenic Diet Shapes the Microbiome to Influence Cancer Immunotherapy Outcomes: An Exploration of Clinical Trials and Their ResultsJonah Bukovac, Marium Husain, Teryn Sapper, et al.
Journal of Cancer Research and Clinical Oncology|August 2, 2019
Change in neutrophil to lymphocyte ratio during immunotherapy treatment is a non-linear predictor of patient outcomes in advanced cancersMingjia Li, Daniel Spakowicz, Jarred Burkart, et al.
Cancer Immunology, Immunotherapy : CII|February 4, 2023
Association of medical comorbidities and cardiovascular disease with toxicity and survival among patients receiving checkpoint inhibitor immunotherapyAndrew C Johns, Mike Yang, Lai Wei, et al.
The Oncologist|April 21, 2023
Risk Factors for Immune Checkpoint Inhibitor Immunotherapy Toxicity Among Older Adults with CancerAndrew C Johns, Mike Yang, Lai Wei, et al.
Cancer Immunology, Immunotherapy : CII|July 31, 2020
Brief report: inhaled corticosteroid use and the risk of checkpoint inhibitor pneumonitis in patients with advanced cancerMingjia Li, Daniel Spakowicz, Songzhu Zhao, et al.
Asia-Pacific Journal of Clinical Oncology|December 20, 2024
Impact of Tobacco, Marijuana, and Alcohol Use on Overall Survival in Recurrent Metastatic Head and Neck Cancer Patients Treated With Immune Checkpoint InhibitorsMohammad Bilal Alsavaf, Majd Issa, Brett G Klamer, et al.
Journal of Cancer Research and Clinical Oncology|September 7, 2022
Immune checkpoint inhibitor-induced hepatitis injury: risk factors, outcomes, and impact on survivalAbdul Miah, Gabriel Tinoco, Songzhu Zhao, et al.
Pageof 4